Humacyte Inc.-CW27HUMAWPreferred / convertible

13F holders, Q1 2026 (March 31)
7holders −1
0new positions
1sold out
$0.09avg. 13F price*

At the end of Q1 2026, 7 institutions reported holding Humacyte Inc.-CW27 (HUMAW) in their 13F filings, down 1 from Q4 2025. 0 opened new positions and 1 sold out. The largest holders were LPL Financial LLC ($24K), Sio Capital Management, LLC ($5K) and Jane Street Group, LLC ($5K).

Company
Humacyte Inc.-CW27
CUSIP
44486Q111
Latest filing quarter
Q2 2026

History

Number of 13F holders

0246810 Q1 2024: 6Q1 2024Q2 2024: 10Q2 2024Q3 2024: 7Q3 2024Q4 2024: 5Q4 2024Q1 2025: 5Q1 2025Q2 2025: 6Q2 2025Q3 2025: 6Q3 2025Q4 2025: 8Q4 2025Q1 2026: 7Q1 2026Q2 2026: 8Q2 2026

Total Exit/New Position Q4 2025 → Q1 2026

InstitutionsTotal Value
New Positions0$0
Exits1$84

All 13F filers, Q4 2025 → Q1 2026: 1,815 shares bought and 34,971 shares sold, net −33,156 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 7 holders

LPL Financial LLC — Add +0.2% 259,615 $24K
Sio Capital Management, LLC — No change 49,998 $5K
Jane Street Group, LLC — Add +0.4% 50,000 $5K
Susquehanna International Group, LLP — Reduce -40.9% 44,517 $4K
Two Sigma Securities, LLC — Reduce -7.1% 42,124 $4K
Wolverine Asset Management LLC — Add +3.0% 37,975 $3K
Toronto Dominion Bank — No change 20,418 $2K

"% of holder's portfolio" is HUMAW's weight in each manager's 13F, not the share of Humacyte Inc.-CW27 the manager owns.